News about Global Pharma

Granules India Expands into Peptide Therapeutics with Acquisition of Senn Chemicals

Senn Chemicals AG brings advanced expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), along with an established customer base in pharmaceuticals, cosmetics, and theragnostic industries.

Global Pharma | 24/02/2025 | By Aishwarya |  877

MGI Tech to Advance Genomic Innovation in Oncological Health

The Oncoclínicas&Co has now another advanced technology for cancer diagnosis with the addition of the medium-throughput DNBSEQ-G400 genomic sequencer.

Global Pharma | 24/02/2025 | By Aishwarya |  186

Lupin Secures EIR from US FDA for its Somerset Manufacturing Facility

Lupin Ltd. has received the Establishment Inspection Report (EIR) from the US FDA for its Somerset, New Jersey facility.

Global Pharma | 21/02/2025 | By Manvi |  1321

Senores Pharmaceuticals Acquires ANDA for Roflumilast 250 mcg and 500 mcg Tablets from Breckenridge Pharmaceutical

Senores Pharmaceuticals Ltd., through its US subsidiary, has acquired the USFDA-approved ANDA for Roflumilast 250 mcg and 500 mcg tablets from Breckenridge Pharmaceutical, strengthening its presence in the chronic bronchitis therapy market.

Global Pharma | 21/02/2025 | By Manvi |  312

Rentschler Biopharma Appoints Patrick Meyer as Global Head of Business Development

Dr. Meyer has been with the Rentschler Biopharma team for over eight years, most recently serving as Global Head BD Sales and Alliance Management.

Global Pharma | 21/02/2025 | By Aishwarya |  726

Cosette Pharmaceuticals Acquires Mayne Pharma to Expand Globally

Cosette will utilize its market-leading commercial and operational capabilities, backed by its 350+ strong team and a leading portfolio of women’s health and dermatology products alongside Mayne Pharma’s complementary strength in these specialty areas.

Global Pharma | 21/02/2025 | By Aishwarya |  838

Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma

Hilberdink will play a pivotal role in fostering Boehringer's culture and driving meaningful impact for patients.

Global Pharma | 21/02/2025 | By Aishwarya |  357

Lantern Pharma Submits PCT Patent Application for Machine Learning Model for BBB Permeability Prediction

The technology has demonstrated to-date exceptional performance in predicting BBB permeability across a wide range of chemical compounds, processing up to 100,000 molecules per hour with industry-leading accuracy.

Global Pharma | 20/02/2025 | By Aishwarya |  283

Orchid Pharma's Alathur API Facility Successfully Completes USFDA Inspection

Orchid Pharma has successfully completed a surprise USFDA inspection at its Alathur API facility, securing its status as India’s only USFDA-approved site for Sterile Cephalosporins. The facility also secures EU GMP certificate renewal for Cephalosporin API manufacturing.

Global Pharma | 20/02/2025 | By Abha |  627

Acurx Pharmaceuticals Secures Japanese Patent for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals has secured a new patent from the Japanese Patent Office for its DNA Polymerase IIIC Inhibitors, expanding its global intellectual property portfolio in antimicrobial drug development.

Global Pharma | 20/02/2025 | By Abha |  308